Advanced Search
Contact | Corporate | Help

Ixabepilone and Carboplatin +/- Bevacizumab in Advanced Non-Small-Cell Lung Cancer

Sponsors:
  • Sarah Cannon Research Institute
  • Bristol-Myers Squibb
  • Genentech
Phases:
  • Phase II
IndicationsAcronym:
  • Non-small Cell Lung Cancer
Age Groups:
  • Adult
  • Senior
Gender:
Both
Names:
  • Drug: Ixabepilone
  • Drug: Carboplatin
  • Drug: Bevacizumab
Enrollment:
78

Additional information about NCT00741988.


SourceSolution © 2008-2012